
Xtum 125mg/62.5mg Injection
Marketer
Shreya Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (125mg) + Sulbactam (62.5mg)
Overview Xtum 125mg/62.5mg Injection
Combiflox, a 125 mg/62.5 mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administer this medication solely under a healthcare provider's guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; escalating symptoms necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occur. Ensure adequate rest, nutrition, and hydration for optimal recovery. Your doctor may order lab tests to monitor therapeutic response.
Primary Ingredients of Xtum 125mg/62.5mg Injection
No text provided to rephrase.
Uses of Xtum 125mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Xtum 125mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Xtum 125mg/62.5mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xtum 125mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Xtum 125mg/62.5mg Injection works:
Xtum injection, containing 125 mg Ceftriaxone and 62.5 mg Sulbactam, employs a dual-action approach to bacterial infection. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xtum 125 mg/62.5 mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xtum, 125 mg/62.5 mg, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Xtum 125 mg/62.5 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xtum 125 mg/62.5 mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Xtum 125 mg/62.5 mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Xtum 125 mg/62.5 mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Xtum 125 mg/62.5 mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Xtum 125mg/62.5mg Injection :
Should you forget a scheduled dose of Xtum 125 mg/62.5 mg Injection, seek advice from your physician.
Facts to Know About Xtum 125mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
